Copyright Reports & Markets. All rights reserved.

Global Naproxen Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Naproxen Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Naproxen Market Size Growth Rate by Product
      • 1.4.2 Tablet
      • 1.4.3 Capsule
      • 1.4.4 Other
    • 1.5 Market by End User
      • 1.5.1 Global Naproxen Market Size Growth Rate by End User
      • 1.5.2 Rheumatoid Arthritis
      • 1.5.3 Gout
      • 1.5.4 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Naproxen Market Size
      • 2.1.1 Global Naproxen Revenue 2014-2025
      • 2.1.2 Global Naproxen Sales 2014-2025
    • 2.2 Naproxen Growth Rate by Regions
      • 2.2.1 Global Naproxen Sales by Regions
      • 2.2.2 Global Naproxen Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Naproxen Sales by Manufacturers
      • 3.1.1 Naproxen Sales by Manufacturers
      • 3.1.2 Naproxen Sales Market Share by Manufacturers
      • 3.1.3 Global Naproxen Market Concentration Ratio (CR5 and HHI)
    • 3.2 Naproxen Revenue by Manufacturers
      • 3.2.1 Naproxen Revenue by Manufacturers (2014-2019)
      • 3.2.2 Naproxen Revenue Share by Manufacturers (2014-2019)
    • 3.3 Naproxen Price by Manufacturers
    • 3.4 Naproxen Manufacturing Base Distribution, Product Types
      • 3.4.1 Naproxen Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Naproxen Product Type
      • 3.4.3 Date of International Manufacturers Enter into Naproxen Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Naproxen Sales by Product
    • 4.2 Global Naproxen Revenue by Product
    • 4.3 Naproxen Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Naproxen Breakdown Data by End User

    6 North America

    • 6.1 North America Naproxen by Countries
      • 6.1.1 North America Naproxen Sales by Countries
      • 6.1.2 North America Naproxen Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Naproxen by Product
    • 6.3 North America Naproxen by End User

    7 Europe

    • 7.1 Europe Naproxen by Countries
      • 7.1.1 Europe Naproxen Sales by Countries
      • 7.1.2 Europe Naproxen Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Naproxen by Product
    • 7.3 Europe Naproxen by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Naproxen by Countries
      • 8.1.1 Asia Pacific Naproxen Sales by Countries
      • 8.1.2 Asia Pacific Naproxen Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Naproxen by Product
    • 8.3 Asia Pacific Naproxen by End User

    9 Central & South America

    • 9.1 Central & South America Naproxen by Countries
      • 9.1.1 Central & South America Naproxen Sales by Countries
      • 9.1.2 Central & South America Naproxen Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Naproxen by Product
    • 9.3 Central & South America Naproxen by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Naproxen by Countries
      • 10.1.1 Middle East and Africa Naproxen Sales by Countries
      • 10.1.2 Middle East and Africa Naproxen Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Naproxen by Product
    • 10.3 Middle East and Africa Naproxen by End User

    11 Company Profiles

    • 11.1 Teva
      • 11.1.1 Teva Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Teva Naproxen Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Teva Naproxen Products Offered
      • 11.1.5 Teva Recent Development
    • 11.2 Kirsch Pharma GmbH
      • 11.2.1 Kirsch Pharma GmbH Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Kirsch Pharma GmbH Naproxen Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Kirsch Pharma GmbH Naproxen Products Offered
      • 11.2.5 Kirsch Pharma GmbH Recent Development
    • 11.3 Aurobindo
      • 11.3.1 Aurobindo Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Aurobindo Naproxen Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Aurobindo Naproxen Products Offered
      • 11.3.5 Aurobindo Recent Development
    • 11.4 Divis Laboratories
      • 11.4.1 Divis Laboratories Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Divis Laboratories Naproxen Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Divis Laboratories Naproxen Products Offered
      • 11.4.5 Divis Laboratories Recent Development
    • 11.5 Taj Pharmaceuticals Limited
      • 11.5.1 Taj Pharmaceuticals Limited Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Taj Pharmaceuticals Limited Naproxen Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Taj Pharmaceuticals Limited Naproxen Products Offered
      • 11.5.5 Taj Pharmaceuticals Limited Recent Development
    • 11.6 Tianxin Pharmaceutical
      • 11.6.1 Tianxin Pharmaceutical Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Tianxin Pharmaceutical Naproxen Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Tianxin Pharmaceutical Naproxen Products Offered
      • 11.6.5 Tianxin Pharmaceutical Recent Development
    • 11.7 Charioteer Pharmaceutical
      • 11.7.1 Charioteer Pharmaceutical Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Charioteer Pharmaceutical Naproxen Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Charioteer Pharmaceutical Naproxen Products Offered
      • 11.7.5 Charioteer Pharmaceutical Recent Development
    • 11.8 Nhwa Pharmaceutical
      • 11.8.1 Nhwa Pharmaceutical Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Nhwa Pharmaceutical Naproxen Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Nhwa Pharmaceutical Naproxen Products Offered
      • 11.8.5 Nhwa Pharmaceutical Recent Development
    • 11.9 Huazhong Pharma
      • 11.9.1 Huazhong Pharma Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Huazhong Pharma Naproxen Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Huazhong Pharma Naproxen Products Offered
      • 11.9.5 Huazhong Pharma Recent Development

    12 Future Forecast

    • 12.1 Naproxen Market Forecast by Regions
      • 12.1.1 Global Naproxen Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Naproxen Revenue Forecast by Regions 2019-2025
    • 12.2 Naproxen Market Forecast by Product
      • 12.2.1 Global Naproxen Sales Forecast by Product 2019-2025
      • 12.2.2 Global Naproxen Revenue Forecast by Product 2019-2025
    • 12.3 Naproxen Market Forecast by End User
    • 12.4 North America Naproxen Forecast
    • 12.5 Europe Naproxen Forecast
    • 12.6 Asia Pacific Naproxen Forecast
    • 12.7 Central & South America Naproxen Forecast
    • 12.8 Middle East and Africa Naproxen Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Naproxen Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Naproxen market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Naproxen market based on company, product type, end user and key regions.

      This report studies the global market size of Naproxen in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Naproxen in these regions.
      This research report categorizes the global Naproxen market by top players/brands, region, type and end user. This report also studies the global Naproxen market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Teva
      Kirsch Pharma GmbH
      Aurobindo
      Divis Laboratories
      Taj Pharmaceuticals Limited
      Tianxin Pharmaceutical
      Charioteer Pharmaceutical
      Nhwa Pharmaceutical
      Huazhong Pharma

      Market size by Product
      Tablet
      Capsule
      Other
      Market size by End User
      Rheumatoid Arthritis
      Gout
      Other

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Naproxen market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Naproxen market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Naproxen companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Naproxen submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Naproxen are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Naproxen market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now